Awakn Life Sciences Announces Its Second Location in the UK for “Awakn Clinics London,” Providing Treatment to the Largest City in the UK Post published:August 4, 2021 Post category:Press Release
Canadians Overwhelmingly Support Legal Access to Psilocybin-Assisted Therapy, Poll Reveals Post published:August 4, 2021 Post category:News
Fireside Project Releases App for Psychedelic Peer Support Post published:August 4, 2021 Post category:Press Release
PsyBio Therapeutics Adds NMDA Receptor Antagonists and Associated Analogues into its Intellectual Property Portfolio Post published:August 4, 2021 Post category:Press Release
Filament Health Is the First Public Company to Be Issued a Patent for Extraction of Natural Psilocybin Post published:August 3, 2021 Post category:Press Release
Cybin Announces Closing of Overnight Marketed Public Offering of Common Shares and Exercise of Over-Allotment Option Post published:August 3, 2021 Post category:Press Release
MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology Post published:August 3, 2021 Post category:Press Release
Psychedelic Bulletin: MindMed Initiates DMT Trial; COMPASS Appoints CMO; Field Trip Lists on NASDAQ Post published:July 30, 2021 Post category:Psychedelic Bulletin
Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements Post published:July 30, 2021 Post category:Press Release
Entheon Biomedical Corp. Acquires Lobo Genetics Inc. Post published:July 30, 2021 Post category:Press Release